Needle-Free Drug Delivery Devices Market Key Players and Opportunities by 2031

The Needle Free Drug Delivery Devices Market size is expected to reach US$ 39.08 Billion by 2031. The market is anticipated to register a CAGR of 8.7% during 2025-2031. Rise in strategic initiatives, and use of healthcare integration software are likely to remain key needle-free drug delivery devices market trends.

Needle-Free Drug Delivery Devices Market Analysis

Needles can lead to various diseases, such as HIV, and injuries if not administered with proper precautions. According to the article “MEDICSEN: NEEDLE-FREE SMARTPATCH FOR PAINLESS DRUG DELIVERY’, over 2,000 people in the US are affected by needlestick injuries per day, generating over US$ 3 billion in associated costs every year. The use of needle-free drug delivery devices decreases the chances of these injuries and diseases. Thus, a surge in the prevalence of needlestick injuries and a rise in spending for treatment fuels the growth of the needle-free drug delivery devices market.

Needle-Free Drug Delivery Devices Market Overview

Needle-free drug deliveries are taken in the form of power sprays, jet injectors, inhalers, and skin patches. Needle-free technology reduces patient concern about using needles. Needle-free devices are effective injections for a wide range of drugs and are bioequivalent to needles. Advantages of needle-free delivery devices include less pain, fast injection, no needle disposal issue, and can be self-administered. Thus, the benefits of needle-free drug delivery devices over conventional needles and syringes are mainly responsible for the increasing demand for needle-free drug delivery devices.

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Needle-Free Drug Delivery Devices Market: Strategic Insights

Needle-Free Drug Delivery Devices Market Drivers and Opportunities

Rising Prevalence of Chronic Diseases and Lifestyle Disorders to Favor Market

Chronic diseases such as heart disease, diabetes, and cancer are the leading causes of death and disability worldwide. As per the Centers for Disease Control and Prevention (CDC), ~38.4 million people in America were suffering from diabetes in 2021. To control the incidence of diabetes, insulin is injected through the subcutaneous layer at regular intervals. Due to an increase in the prevalence of diabetes, the demand for insulin injections is also growing. The companies are focusing on developing needle-free insulin devices to avoid needlestick injuries. For instance, Medicsen is focusing on developing SmartPatch to deliver insulin with more efficacy.

Rising Preference for Home Healthcare – An Opportunity for Needle-Free Drug Delivery Market

A shift from hospitals, long-term facilities, inpatient rehabilitation, and skilled nursing facilities to home care settings results in greater chances of better, consistent, and timely interaction between patient and doctor owing to the growing utilization of cloud and mobility-driven medical devices. In developing countries, the number of patients receiving home therapy has been limited in the past. The smart patches and jet injectors are integrated with electronic health records (EHR), allows doctors to monitor the dosage for anywhere. With the help of needle-free drug delivery devices, the patient can easily self-administer their drugs according to the requirements prescribed by the doctor. Thus, an increase in focus on home healthcare and the use of technologically integrated products is expected to act as an opportunity for growth of the market during the forecast period.

Needle-Free Drug Delivery Devices Market Report Segmentation Analysis

Key segments that contributed to the derivation of the needle-free drug delivery devices market analysis are type and application.

1. Based on type, the needle-free drug delivery devices market is segmented into inhalers, jet injectors, novel needles, transdermal patches, and others. The jet injectors segment held the largest market share in 2023.
2. By application, the market is segmented into insulin delivery, vaccination, pain management, and others. The insulin delivery disease segment dominated the market in 2023.

Needle-Free Drug Delivery Devices Market Share Analysis by Geography

The geographic scope of the needle-free drug delivery devices market report is mainly segmented into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America.

North America dominated the needle-free drug delivery devices market in 2023. The market growth in North America is characterized by increased demand for rare disease medications from biopharmaceutical and biotechnology companies, the presence of key market players, an increase in product launches, a rise in the burden of needle stick injuries, and extensive R&D conducted by academic and research institutes and pharmaceutical and biotechnology companies. Moreover, Asia Pacific is anticipated to record the highest CAGR in the coming years.

Needle-Free Drug Delivery Devices Market News and Recent Developments

The needle-free drug delivery devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for needle-free drug delivery devices and strategies:

1. NovaXS, which was formed at the University of California, Berkeley, designed its patent-pending Telosis technology to administer a narrow stream of medication without a needle in 0.3 seconds and to analyze injection data to allow for smarter health decisions. (Source: NovaXS BIotech, Press Release, 2022)
2. NuGen Medical Devices Inc. launched InsuJet devices in Canada. SOL-MILLENNIUM Medical Group has registered as an exhibitor at the 2022 Diabetes Canada/Canadian Society of Endocrinology and Metabolism (CSEM) Professional Conference, where it launched the InsuJet product for Canada. (Source: NuGen Medical Devices Inc, Company Website, 2022)

The regional trends and factors influencing the Needle-Free Drug Delivery Devices Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Needle-Free Drug Delivery Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Needle-Free Drug Delivery Devices Market Report Scope

Needle-Free Drug Delivery Devices Market Players Density: Understanding Its Impact on Business Dynamics

The Needle-Free Drug Delivery Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Needle-Free Drug Delivery Devices Market Report Coverage and Deliverables

The “Needle-Free Drug Delivery Devices Market Size and Forecast (2023–2031)” report provides a detailed analysis of the market covering below areas:

1. Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
2. Market dynamics such as drivers, restraints, and key opportunities
3. Key future trends
4. Detailed PEST and SWOT analysis
5. Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
6. Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
7. Detailed company profiles